Gas-liquid interfaces of gastrointestinal foam bubbles

The gas-liquid interfaces of gastrointestinal foam bubbles serve as a unique physical target for therapeutic agents designed to alleviate symptoms of intestinal gas. In the gastrointestinal tract, gas can become trapped in a stable foam of small bubbles, often stabilized by mucus or food components, which leads to abdominal distension, bloating, and pain (Mayo Clinic, 2024). Pharmacological agents such as simethicone target these interfaces by significantly lowering their surface tension (StatPearls, 2023). This action causes the small, stable bubbles to rupture and coalesce into larger gas pockets, which are then more readily eliminated from the body through natural processes like eructation or flatulence (NIH, 2022). Because this target is purely physical and located within the lumen of the gut, the interacting drugs are generally inert and not absorbed systemically, resulting in a high safety profile (PubChem, CID 6433515). Furthermore, targeting these interfaces is a standard practice during endoscopic procedures to clear foam and improve the diagnostic quality of the visualization (PubMed, 2011).

Other names

Gastrointestinal gas-liquid interfaceIntestinal gas bubblesGI foamGastrointestinal foam

Reduction of surface tension at the gas-liquid interface, facilitating the coalescence of small, trapped bubbles into larger gas masses that are more easily expelled (StatPearls, 2023; Mayo Clinic, 2024).